Business Description
Sinil Pharmaceutical Co Ltd
SIC : 111
ISIN : KR7012790002
Compare
Compare
Traded in other countries / regions
012790.Korea IPO Date
1999-08-13Description
Sinil Pharmaceutical Co Ltd is a South Korean drug manufacturing company. The products of the company include diphene gel, tour pen plasta, oriental herb tea cold liquid, and griffen ssung.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 53.01 | |||||
| Equity-to-Asset | 0.87 | |||||
| Debt-to-EBITDA | 0.03 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 4.74 | |||||
| Beneish M-Score | -1.85 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 13.3 | |||||
| 3-Year EBITDA Growth Rate | 17.3 | |||||
| 3-Year EPS without NRI Growth Rate | 24.3 | |||||
| 3-Year FCF Growth Rate | -4.8 | |||||
| 3-Year Book Growth Rate | 6.9 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 55.96 | |||||
| 9-Day RSI | 55.3 | |||||
| 14-Day RSI | 54.23 | |||||
| 6-1 Month Momentum % | -7.36 | |||||
| 12-1 Month Momentum % | -13.39 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.29 | |||||
| Quick Ratio | 2.95 | |||||
| Cash Ratio | 1.61 | |||||
| Days Inventory | 165.5 | |||||
| Days Sales Outstanding | 88.89 | |||||
| Days Payable | 42.06 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.35 | |||||
| Dividend Payout Ratio | 0.15 | |||||
| 3-Year Dividend Growth Rate | 23.3 | |||||
| Forward Dividend Yield % | 2.35 | |||||
| 5-Year Yield-on-Cost % | 3.22 | |||||
| 3-Year Average Share Buyback Ratio | -0.9 | |||||
| Shareholder Yield % | 2.28 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 41.72 | |||||
| Operating Margin % | 14.92 | |||||
| Net Margin % | 15 | |||||
| FCF Margin % | 9.11 | |||||
| ROE % | 10.29 | |||||
| ROA % | 8.98 | |||||
| ROIC % | 10.6 | |||||
| ROC (Joel Greenblatt) % | 21.22 | |||||
| ROCE % | 11.29 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 6.19 | |||||
| PE Ratio without NRI | 6.19 | |||||
| Shiller PE Ratio | 7.92 | |||||
| Price-to-Owner-Earnings | 12.34 | |||||
| PEG Ratio | 0.41 | |||||
| PS Ratio | 0.92 | |||||
| PB Ratio | 0.61 | |||||
| Price-to-Tangible-Book | 0.62 | |||||
| Price-to-Free-Cash-Flow | 10.19 | |||||
| Price-to-Operating-Cash-Flow | 4.13 | |||||
| EV-to-EBIT | 3.76 | |||||
| EV-to-EBITDA | 3.74 | |||||
| EV-to-Revenue | 0.64 | |||||
| EV-to-FCF | 6.45 | |||||
| Price-to-Projected-FCF | 0.45 | |||||
| Price-to-Median-PS-Value | 0.49 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.47 | |||||
| Price-to-Graham-Number | 0.41 | |||||
| Price-to-Net-Current-Asset-Value | 1.64 | |||||
| Price-to-Net-Cash | 13.79 | |||||
| Earnings Yield (Greenblatt) % | 26.62 | |||||
| FCF Yield % | 9.8 | |||||
| Forward Rate of Return (Yacktman) % | 19.33 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sinil Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 90,063.53 | ||
| EPS (TTM) (â‚©) | 1169 | ||
| Beta | 1.18 | ||
| Volatility % | 22.54 | ||
| 14-Day RSI | 54.23 | ||
| 14-Day ATR (â‚©) | 216.344147 | ||
| 20-Day SMA (â‚©) | 7125 | ||
| 12-1 Month Momentum % | -13.39 | ||
| 52-Week Range (â‚©) | 6280 - 8250 | ||
| Shares Outstanding (Mil) | 11.56 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sinil Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sinil Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sinil Pharmaceutical Co Ltd Frequently Asked Questions
What is Sinil Pharmaceutical Co Ltd(XKRX:012790)'s stock price today?
The current price of XKRX:012790 is â‚©7240.00. The 52 week high of XKRX:012790 is â‚©8250.00 and 52 week low is â‚©6280.00.
When is next earnings date of Sinil Pharmaceutical Co Ltd(XKRX:012790)?
The next earnings date of Sinil Pharmaceutical Co Ltd(XKRX:012790) is .
Does Sinil Pharmaceutical Co Ltd(XKRX:012790) pay dividends? If so, how much?
The Dividend Yield %  of Sinil Pharmaceutical Co Ltd(XKRX:012790) is 2.35% (As of Today), Highest Dividend Payout Ratio of Sinil Pharmaceutical Co Ltd(XKRX:012790) was 0.26. The lowest was 0.08. And the median was 0.13. The  Forward Dividend Yield % of Sinil Pharmaceutical Co Ltd(XKRX:012790) is 2.35%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers